|
FOR IMMEDIATE RELEASE CONTACT: Matt Hill, NFL, 212-450-2080 Howard Clabo, FedEx, 901-434-7786 NFL.COM VOTERS SELECT Quarterback DREW BREES of the San Diego Chargers and running back JEROME BETTIS of the Pittsburgh Steelers are the FedEx Air & Ground NFL Players of the Week for games played on November 7-8, the NFL announced today. Brees completed 22 of 36 passes for 257 yards, four touchdowns and a passer rating of 119.8 in the Chargers’ 43-17 victory over the New Orleans Saints. He connected with tight end Antonio Gates for touchdowns of two, seven and 12 yards and finished with four touchdown passes after throwing five last week. Bettis ran for 149 yards on 33 carries as the Steelers beat the previously-undefeated Philadelphia Eagles 27-3. He helped the Steelers drive for touchdowns on their first three possessions. Brees and Bettis were selected from among finalists in the air and ground categories through 73,328 fan votes. The other FedEx Express NFL Player of the Week finalists were quarterbacks PEYTON MANNING of the Indianapolis Colts and JAKE PLUMMER of the Denver Broncos, while running backs SHAUN ALEXANDER of the Seattle Seahawks and MICHAEL PITTMAN of the Tampa Bay Buccaneers were the other finalists for FedEx Ground NFL Player of the Week. Fans voted for more than their favorite players. The weekly FedEx Air & Ground NFL Players of the Week Awards are also a win for the local community. Along with the player awards, FedEx is awarding the Children's Hospital Foundation and Children's Hospital of Pittsburgh, the Children’s Hospital in each winning market, a check for $5,000. The children’s hospitals in the two season-long winner’s markets, announced at this year’s Super Bowl, will be awarded $25,000 each. That means that FedEx will deliver nearly $250,000 to local children’s hospitals around the country in recognition of the FedEx Air & Ground NFL Players of the Week Award winners. FedEx, the premier global provider of transportation, e-commerce and supply-chain management services, is the Official Delivery Service Sponsor of the NFL, Super Bowl and Pro Bowl. Through the weekly FedEx Air and Ground awards, FedEx recognizes those NFL players who represent the same speed, precision and teamwork that their customers have come to expect from the full range of FedEx air, ground, freight and international shipping services. 2004 FEDEX AIR & GROUND NFL PLAYERS OF THE WEEK
FOR IMMEDIATE RELEASE CONTACT: MATT HILL, NFL, 212-450-2080 DAVE DECECCO, PEPSI-COLA, 914-253-2655 NFL.COM VOTERS SELECT STEELERS QB BEN ROETHLISBERGER Voters on NFL.com have made their choice. Quarterback BEN ROETHLISBERGER of the Pittsburgh Steelers is the PEPSI NFL ROOKIE OF THE WEEK for games played on November 7-8, the NFL announced today. Roethlisberger completed 11 of 18 passes for 183 yards and two touchdowns in the Steelers’ 27-3 victory over the Philadelphia Eagles. He connected with wide receiver Hines Ward and tight end Jay Riemersma on touchdown passes of 20 and two yards respectively. Roethlisberger is 6-0 as an NFL starter and has now collected six Pepsi Rookie of the Week awards. More than 58,900 fans voted this week on NFL.com. Roethlisberger was selected from among five finalists. The other finalists were wide receiver LEE EVANS of the Buffalo Bills, wide receiver LARRY FITZGERALD of the Arizona Cardinals, quarterback CRAIG KRENZEL of the Chicago Bears and safety MADIEU WILLIAMS of the Cincinnati Bengals. After the regular season, five players will be nominated for Pepsi NFL Rookie of the Year honors. Fans can vote for the winner on NFL.com throughout the month of January. The winner will be announced at a press conference at Super Bowl XXXIX in Jacksonville. This is Pepsi’s third year as the official soft drink sponsor of the NFL. 2004 PEPSI NFL ROOKIE OF THE WEEK
Contact :Seth Rubin
Matt Hill ED REED’S INTERCEPTION RETURN FOR A TOUCHDOWN NAMED NEW YORK—NOVEMBER 11, 2004 – Baltimore Ravens safety Ed Reed’s NFL record-breaking 106-yard interception return for a touchdown against the Cleveland Browns has been voted "LEVITRAâ (vardenafil HCI) PLAY OF THE WEEK" for NFL games played November 7-8.Reed’s impressive touchdown is now eligible to be selected as the "LEVITRAâ PLAY OF THE YEAR," awarded this February at Super Bowl XXXIX in Jacksonville, Florida. "LEVITRAâ PLAY OF THE WEEK," which is voted on by fans each week throughout the NFL season from Tuesday at noon ET to Thursday at noon ET on NFL.com, is presented each Thursday and recognizes the single most exciting play that week. Fans who vote at NFL.com each week can also enter for their chance to win a three-day/two-night trip for two to Jacksonville, Florida to attend Super Bowl XXXIX on February 6, 2005, including round-trip airfare and hotel accommodations. With the Ravens clinging to a 20-13 lead with under a minute to play and the Browns threatening to score, Reed picked off a pass in his own end zone and ran the length of the field for an NFL-record 106-yard interception return for a touchdown. The Ravens’ safety picked off the pass after it deflected off of the hands of a Browns receiver. Reed's touchdown secured the Ravens' 27-13 victory over their AFC North divisional rivals. Reed beat out Cincinnati Bengals tight end Matt Schobel’s 76-yard touchdown reception from quarterback Carson Palmer against the Dallas Cowboys in fan voting on NFL.com. For details and video of this week’s nominees and the results of fan voting, please visit www.NFL.com/playoftheweek In July 2003, Bayer Pharmaceutical Corporation (Bayer) & GlaxoSmithKline(GSK), co-marketers of LEVITRA (vardenafil HCI), a prescription medicine that is used to treat erectile dysfunction (ED), announced their groundbreaking sponsorship of the NFL. 2004 LEVITRAâ PLAY OF THE WEEK Winners
About LEVITRA LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate problems, also should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level. You should not take LEVITRA if your doctor determines that sexual activity poses a health risk for you. Men who experience an erection for more than four hours should seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases .The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking certain medications such as ritonavir, indinavir, ketoconazole, itraconazole, and erythromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended. In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets. About Erectile Dysfunction The consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance1 – is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than one half of all men over the age of 402– 152 million men worldwide3 and 30 million men in the United States alone.4 Despite the high prevalence of sexual problems, nine out of 10 men in the U.S. have not yet sought treatment from a physician.5 1. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d’Urologie (SIU) and held July 1-3, 1999, Paris. 2000, p. 713. 2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61. 3. Aytac IA, McKinlay JB, Krane RI. The likely worldwide increase of erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56 4. National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: http://odp.od.nih.gov/consensus/cons/091/091_statement.htm. (accessed 8/26/02). 5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544. About Bayer Pharmaceuticals Corporation Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease. Forward Looking Statement This news release contains forward-looking
statements based on current assumptions and forecasts made by Bayer Group
management. Various known and unknown risks, uncertainties and other factors
could lead to material differences between the actual future results,
financial situation, development or performance of the company and the
estimates given here. These factors include those discussed in Bayer’s
public reports filed with the Frankfurt Stock Exchange and with the U.S.
Securities and Exchange Commission (including its Form 20-F). Bayer assumes
no liability whatsoever to update these forward-looking statements or to
conform them to future events or developments. About GSK GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information about LEVITRA, please visit www.LEVITRA.com. ### |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||